229.26

INR
-11.16(-4.64%)
As of November 14, 2024 10:00:00 AM

Wanbury Limited Share Price Information

24 hour Low and High

Low: 229.25999451
High: 229.25999451

All time High

281.37

Price Change 1h

+₹-0.00 +-0.00%

Price Change 1d

+₹-0.00 +-0.00%

Price Change 1w

+₹-30.69 +-11.81%

Wanbury Limited Market Information

Exchange

NSE

Market Cap

746.78 Cr

About Wanbury Limited Share

Wanbury Limited manufactures and sells formulations and active pharmaceutical ingredients (API) in India and internationally. The company offers formulations for gynecology, orthopedics, hematinic, anti-diabetic, nutraceuticals, gastro intestinal, stroke surgery, antibiotics, cough and cold solutions, anti-inflammatory, analgesics, and general practitioner. It also provides API products for anti-diabetic, anti-analgesic, anti-depressant, anti-histaminic, anti-inflammatory, anti-arthritis, anti-thrombotic, anti-epileptic, and anti-hypertensive therapeutic areas. The company was formerly known as Pearl Organics Limited and changed its name to Wanbury Limited in 2004. Wanbury Limited was incorporated in 1988 and is headquartered in Navi Mumbai, India.

Sector

Healthcare

Drug Manufacturers - Specialty & Generic

Employees

about

1491

CEO

Mr. Pradeep Patni

Revenue (2023)

%

Country of Origin

India

Key Highlights

  • Wanbury surges 5% after USFDA issues Zero observations for Patalganga site
  • Wanbury Q4 Results Live : profit rise by 3211.99% YOY | Company Business News
  • Wanbury Shares Hit 5% Upper Circuit on API Pipeline and Launches
  • Wanbury Limited (NSE:WANBURY) Surges 35% Yet Its Low P/S Is No Reason For Excitement
  • Wanbury shares rise 5% after clean US FDA report on Patalganga facility

FAQs

229.26

INR
-11.16(-4.64%)
As of November 14, 2024 10:00:00 AM

Wanbury Limited Share Price Information

24 hour Low and High

Low: 229.25999451
High: 229.25999451

All time High

281.37

Price Change 1h

+₹-0.00 +-0.00%

Price Change 1d

+₹-0.00 +-0.00%

Price Change 1w

+₹-30.69 +-11.81%

Wanbury Limited Market Information

Exchange

NSE

Market Cap

746.78 Cr

About Wanbury Limited Share

Wanbury Limited manufactures and sells formulations and active pharmaceutical ingredients (API) in India and internationally. The company offers formulations for gynecology, orthopedics, hematinic, anti-diabetic, nutraceuticals, gastro intestinal, stroke surgery, antibiotics, cough and cold solutions, anti-inflammatory, analgesics, and general practitioner. It also provides API products for anti-diabetic, anti-analgesic, anti-depressant, anti-histaminic, anti-inflammatory, anti-arthritis, anti-thrombotic, anti-epileptic, and anti-hypertensive therapeutic areas. The company was formerly known as Pearl Organics Limited and changed its name to Wanbury Limited in 2004. Wanbury Limited was incorporated in 1988 and is headquartered in Navi Mumbai, India.

Sector

Healthcare

Drug Manufacturers - Specialty & Generic

Employees

about

1491

CEO

Mr. Pradeep Patni

Revenue (2023)

%

Country of Origin

India

Key Highlights

  • Wanbury surges 5% after USFDA issues Zero observations for Patalganga site
  • Wanbury Q4 Results Live : profit rise by 3211.99% YOY | Company Business News
  • Wanbury Shares Hit 5% Upper Circuit on API Pipeline and Launches
  • Wanbury Limited (NSE:WANBURY) Surges 35% Yet Its Low P/S Is No Reason For Excitement
  • Wanbury shares rise 5% after clean US FDA report on Patalganga facility

FAQs